Intelligence · Clinical Pipeline
Lxo Ireland Designated Pipeline
All ClinicalTrials.gov programs at Lxo Ireland Designated — phase, modality, and trial IDs.
- Programs
- 68
Quick answer
Lxo Ireland Designated has 68 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Allo-depleted lymphocyte infusion
Lxo Ireland Designated Activity Company
Transplant-Related Hematologic Malignancy
1 trial -
CEA protein antigen plus BCG Vaccine Mix for percutaneous use
Lxo Ireland Designated Activity Company
Rectal Cancer
1 trial -
COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use
Lxo Ireland Designated Activity Company
Covid19
1 trial -
Carfilzomib
Lxo Ireland Designated Activity Company
Acute Lymphoblastic Leukemia (ALL)
1 trial -
DT-216
Lxo Ireland Designated Activity Company
Friedreich Ataxia
2 trials -
GLA-AF
Lxo Ireland Designated Activity Company
Healthy Volunteers
1 trial -
GLA-SE
Lxo Ireland Designated Activity Company
Merkel Cell Carcinoma
1 trial -
HIV Therapeutic Biologic Mix - HIV GP160 plus BCG Vaccine Mix for percutaneous use
Lxo Ireland Designated Activity Company
HIV Infections
1 trial -
HSV 2 Formulation 1
Lxo Ireland Designated Activity Company
Genital Herpes
1 trial -
ID-LV305
Lxo Ireland Designated Activity Company
Melanoma - Currently Enrolling
1 trial -
IDC-G305
Lxo Ireland Designated Activity Company
Melanoma
1 trial -
Infudopa i.v.
Lxo Ireland Designated Activity Company
Parkinson Disease
1 trial -
MSD-001
Lxo Ireland Designated Activity Company
Mental Health Disorders
1 trial -
Novel restraint
Lxo Ireland Designated Activity Company
Acute Respiratory Failure
1 trial -
Switch active lifestyles brought to you by MediaWise
Lxo Ireland Designated Activity Company
Overweight
1 trial -
Hyperbaric bupivacaine+Sufentanil
Lxo Ireland Designated Activity Company
Anesthesia; Functional
1 trial -
Low intensity laser for oral mucositis
Lxo Ireland Designated Activity Company
Oral Mucositis
1 trial -
Pre-dilation side branch
Lxo Ireland Designated Activity Company
Coronary Angiography
1 trial -
Roflumilast alternated days
Lxo Ireland Designated Activity Company
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Subcutaneous glargine insulin
Lxo Ireland Designated Activity Company
Diabetes Mellitus
1 trial
Frequently asked questions
How many pipeline programs does Lxo Ireland Designated have?
68 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs